This study aims to compare two available types of central venous haemodialysis catheters (lines) - CVCs, and will examine how easy they are to insert, complications, blood flow on dialysis over time, line loss, line clotting and infective events. It will examine whether the LifeCath type of CVC can deliver high blood flow rates from first use after insertion and equivalent function and complication rate to the Tesio type of CVC that is in use in our centre already. Complications relating to dialysis access make up 30% of admissions for haemodialysis patients and so this is a study that could benefit patients and their care providers.
Complications relating to dialysis access make up to 30% of admissions in haemodialysis patients. Comparative studies of complications between dialysis lines can help physicians and patients choose the best CVC type. In addition determining a type of dialysis line that can deliver good blood flows from the outset can minimise length of hospital stay for access creation. This study aims to perform a head-to-head comparison of two very similar (twin catheter) dialysis lines and examine short and long-term function as well as complication rates at our centre.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
80
Insertion of the TesioCath(TM) central venous catheter for haemodialysis vascular access
Insertion of the LifeCath Twin central venous catheter for haemodialysis vascular access
Imperial College Healthcare NHS Trust
London, United Kingdom
Blood Flow Rate at First Use After Insertion
Time frame: First haemodialysis session after insertion
Achievement of Flow Rates>=450ml/Min at Dialysis Session
Time frame: flow rate measured at each session; session at 12 months reported
Line Retention (Either/Both Lumens)
Time frame: 12 months
Infective Episodes (Catheter & Non-catheter Related)
Time frame: 12 months
Catheter Dysfunction Requiring Use of Thrombolytic Agents
Time frame: 12 months
Complications at Catheter Insertion
Time frame: Day 1
Recirculation Rates
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.